# NCT05608044 (NCT05608044)

> A Study of Botensilimab and Balstilimab for the Treatment of Colorectal Cancer

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT05608044
- Phase: PHASE2
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Agenus Inc.
- Conditions: Metastatic Colorectal Cancer
- Interventions: Botensilimab; Balstilimab; Standard of Care
- Enrollment: 234
- Primary outcome: Objective Response Rate

## Indexed commentary on NCT05608044 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- 3 posts on X

## Order

Focused, $750 at most (a smaller delivered size costs its own price): https://www.erudio.com/contact?report=nct05608044